Table 3.
Variables | Deterioration of PV–IVH n = 42 |
No deterioration of PV–IVH n = 472 |
X2 | P |
---|---|---|---|---|
WBC > 25 × 109/La (n, %) | 15 (35.7) | 95 (20.1) | 5.571 | 0.02 |
CRP > 8 mg/L (n, %) | 14 (33.3) | 86 (18.2) | 5.622 | 0.02 |
Progressive decrease in platelets (n, %) | 4 (9.5) | 27 (5.7) | N | 0.31 |
Abnormal coagulation (n, %) | 7 (16.7) | 142 (30.1) | 3.373 | 0.07 |
Blood glucose < 2.2 mmol/L (n, %) | 1 (2.4) | 48 (10.2) | 2.713 | 0.10 |
Albumin < 30 g/L (n, %) | 15 (35.7) | 209 (44.3) | 1.151 | 0.28 |
Invasive respiratory support (n, %) | 26 (61.9) | 149 (31.6) | 15.807 | 0.00 |
Non-invasive respiratory support (n, %) | 2 (4.8) | 22 (4.7) | N | 1.00 |
Pulmonary surfactant (n, %) | 29 (69.0) | 240 (50.8) | 5.121 | 0.02 |
Dopamine (n, %) | 22 (52.4) | 108 (22.9) | 17.763 | 0.00 |
Antibiotics (n, %) | 11 (26.2) | 264 (55.9) | 13.714 | 0.00 |
Plasma transfusion (n, %) | 2 (4.8) | 14 (3.0) | N | 0.38 |
Intravenous immunoglobulin (n, %) | 2 (4.8) | 52 (11.0) | 1.605 | 0.21 |
PV–IVH periventricular–intraventricular hemorrhage, WBC white blood cell, CRP C-reactive protein.
aBaseline values were tested before or within PV–IVH diagnosis.